Fever News and Research

RSS

Cuts to health budget lead to increases in HIV/AIDS, malaria, TB incidence in Greece

"The savage cuts to Greece's health service budget have led to a sharp rise in HIV/AIDS and malaria in the beleaguered nation, said a leading aid organization on Thursday," the Guardian's "News Blog" reports.

17 Mar 2012

Warming climate may increase risk from Chagas disease

In the spring of 1835, Charles Darwin was bitten in Argentina by a "great wingless black bug," he wrote in his diary. "It is most disgusting to feel soft wingless insects, about an inch long, crawling over one's body," Darwin wrote, "before sucking they are quite thin, but afterwards round & bloated with blood."

16 Mar 2012

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Abbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa.

16 Mar 2012

GenVec 2011 net loss decreases to $7.4 million

Today GenVec, Inc. announced financial results for the fourth quarter and year ended December 31, 2011. For the year ended December 31, 2011, the Company reported a net loss of $7.4 million, or $0.58 per share, compared with a net loss of $12.3 million, or $0.97 per share, for the year ended December 31, 2010.

15 Mar 2012

Scientists discover direct biomarker of Chikungunya fever

Recent breakthroughs in Chikungunya research spearheaded by scientists at A*STAR's Singapore Immunology Network (SIgN) have made great strides in the battle against the infectious disease.

15 Mar 2012

Researchers discover how Salmonella thrives in the digestive tract

UC Irvine researchers have discovered how Salmonella, a bacterium found in contaminated raw foods that causes major gastrointestinal distress in humans, thrives in the digestive tract despite the immune system's best efforts to destroy it.

15 Mar 2012

Antibody-based therapies successfully protect monkeys from deadly Ebola and Marburg viruses

Army scientists have demonstrated, for the first time, that antibody-based therapies can successfully protect monkeys from the deadly Ebola and Marburg viruses. In addition, the animals were fully protected even when treatment was administered two days post-infection, an accomplishment unmatched by any experimental therapy for these viruses to date.

14 Mar 2012

Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints

Pfizer Inc. announced today that data from a Phase 3 study of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and establishing a safety profile in children and adolescents aged 5 through 17 years.

12 Mar 2012

Top-line results from Inviragen's INV21 Phase 1 trial on HFMD

Inviragen today reported top-line results of a placebo-controlled, randomized Phase 1 trial of INV21, the Company's highly purified virus particle vaccine against Hand, Foot and Mouth Disease (HFMD) caused by enterovirus 71.

12 Mar 2012

Doctors identify promising new treatment for hypophosphatasia

Doctors at Washington University School of Medicine in St. Louis, working with Shriners Hospital for Children and other institutions, have identified a promising new treatment for a rare and sometimes life-threatening bone disorder that can affect infants and young children.

8 Mar 2012

Parallels between federal health law and Massachusetts overhaul still a flashpoint for Romney

The Massachusetts health law signed by then-Gov. Mitt Romney is a hot topic on the campaign trail leading up to Super Tuesday. Meanwhile, new polling results indicate President Barack Obama's support among women voters is on the rise.

7 Mar 2012

Sun-dried tomatoes may be contaminated with hepatitis A virus: Officials warn

The Health Protection Agency (HPA) said two confirmed cases of the infection had been found to have an identical strain to three cases reported in England and confirmed at HPA Colindale in 2010. Both people had recently eaten sun-dried tomatoes.

5 Mar 2012

FDA confirms FluCide pre-IND meeting date with NanoViricides

NanoViricides, Inc. announced today that March 29th, 2012 has been confirmed by the US FDA as the date for its initial meeting with the Company's scientists. This pre-IND meeting will focus on FluCide, designated as NV-INF-1, the Company's novel anti-influenza drug.

5 Mar 2012

Meda announces positive results from three MP29-02 studies on allergic rhinitis

Meda announced today positive results of three studies of MP29-02 (tentatively called Dymista), a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate.

5 Mar 2012

Study examines relationship between conflict, rise in NTDs in Middle East, North Africa

A study published in PLoS Neglected Tropical Disease on Tuesday examines the relationship between political conflict in the Middle East and North Africa (MENA) region and "the spread or re-emergence of a variety of tropical diseases -- some previously eliminated or controlled -- affecting an estimated 65 million people" in the region, VOA News reports.

3 Mar 2012

Quadrivalent flu vaccine that fights against four strains of Influenza approved

The FluMist Quadrivalent vaccine from AstraZeneca's MedImmune unit protects against two strains of influenza A and two strains of influenza B, and is approved for people ages 2 to 49. Similar to the previously approved FluMist, the new vaccine is a nasal spray that delivers weakened strains of the virus. The vaccine, FluMist Quadrivalent (MedImmune), will be available for the 2013-2014 flu season.

2 Mar 2012

WHO, PAHO release new guidelines on mosquito-borne chikungunya virus

The Pan-American Health Organization (PAHO), a regional arm of the World Health Organization (WHO), on Tuesday "unveiled new guidelines to help countries throughout the Americas detect and prevent transmission of the mosquito-borne chikungunya virus -- a disease which has already infected more than two million people around the world," the U.N. News Centre reports.

2 Mar 2012

Ten symptoms and signs that a child may need a doctor

Unfortunately, kids get sick. Fighting a virus or common cold is good for a child's immune system and can help build antibodies that protect them from dangerous illnesses. Still, there are times when that tummy ache or cough may require medical attention.

2 Mar 2012

FDA approves MedImmune's FluMist Quadrivalent vaccine

MedImmune today announced that the U.S. Food and Drug Administration (FDA) has approved FluMist Quadrivalent (Influenza Vaccine Live, Intranasal) for prevention of influenza.

29 Feb 2012

WUSM to study children with weakened immune systems

Not all viruses make us sick. But which ones are friends and which ones are foes? Researchers at Washington University School of Medicine in St. Louis have received a five-year, $3.3 million grant to study children with weakened immune systems to identify the viruses that make children sick.

29 Feb 2012